Loading...
XSHE
300357
Market cap2.44bUSD
Oct 27, Last price  
33.08CNY
1D
0.52%
1Q
26.65%
Jan 2017
-5.54%
IPO
-36.88%
Name

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
No data to show
P/E
54.50
P/S
18.72
EPS
0.61
Div Yield, %
0.56%
Shrs. gr., 5y
Rev. gr., 5y
7.68%
Revenues
925m
+9.10%
37,407,15959,327,652103,176,299147,517,280193,609,754239,511,105267,105,585312,085,773385,576,841500,744,692639,352,853636,208,242807,691,606896,016,141848,190,443925,394,524
Net income
318m
+2.46%
10,513,19318,405,87937,264,72953,773,77270,564,34999,554,760117,820,024129,200,974186,103,945232,884,097298,296,581278,447,284337,991,284348,773,471310,184,878317,822,381
CFO
262m
-32.42%
12,628,50014,537,87119,149,70341,166,42658,303,54083,703,086114,820,239122,772,455159,134,139206,452,525232,925,579256,221,705360,575,120360,279,064388,318,565262,440,005
Dividend
Jul 04, 20240.185 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, researches, develops, produces, and sells pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. It also offers skin care and stem cells series. The company is headquartered in Huzhou, China.
IPO date
Jan 21, 2014
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT